Opinion

Video

Novel Investigational Approaches For the Treatment of Neovascular AMD

Author(s):

Paul Hahn, MD, PhD, FASRS,Michael Cohen, MD, FAAO

Dr Paul Hahn and Dr Michael Cohen explore upcoming treatments featuring innovative mechanisms of action and novel delivery systems for addressing neovascular AMD.

1:00 Retina specialists’ wish list for innovative therapies

6:40 Home OCT

8:43 Extending treatment intervals beyond four months

9:40 Therapies in the pipeline

15:00 Need for long-term retinal fluid suppression

16:00 Gene therapy

22:00 Helping patients facing end-stage vision loss

Related Videos
Quan Dong Nguyen, MD: Phase 2 Neptune Trial Advances Brepocitnib for Uveitis | Image Credit: Stanford University
Charles C. Wykoff, MD, PhD: Phase 1b/2a Results on Restoret for DME, nAMD | Image Credit: Retina Consultants of Texas
Christine N. Kay, MD | Image Credit: Atsena Therapeutics
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
Christine N. Kay, MD: Interim Data on ATSN-201 Shows Promise for XLRS | Image Credit: Vitreo Retinal Associates
Arshad Khanani, MD: First Results from Fellow Eye Dosing of RGX-314 in nAMD | Image Credit: Sierra Eye Associates
Joel A. Pearlman, MD, PhD: Phase 2a Data on Oral RZ402 for DME | Image Credit: Retina Consultants Medical Group
Roger A. Goldberg, MD: Pooled Visual Function Data of NT-501 for MacTel | Image Credit: Bay Area Retina Associates
Related Content
Gildeuretinol Shows Promise in Slowing Geographic Atrophy Progression | Image Credit: The Retina Group of Washington
October 21st 2024

Gildeuretinol Shows Promise in Slowing Geographic Atrophy Progression

Connor Iapoce
New Insight: A Look at Corneal Transplant Alternatives w/ John Sheets, PhD | Image Credit: HCPLive
September 5th 2024

New Insight: A Look at Corneal Transplant Alternatives w/ John Sheets, PhD

Connor Iapoce
Face Masking Did Not Affect Endophthalmitis Rates After Anti-VEGF Injections | Image Credit: Wills Eye Hospital
October 21st 2024

Face Masking Did Not Affect Endophthalmitis Rates After Anti-VEGF Injections

Connor Iapoce
MEDcast logo
August 1st 2024

Optimizing Treatment Outcomes in Retinal Vein Occlusion

Hong-Uyen Hua, MD Sruthi Arepalli, MD Geeta Lalwani, MD
SKYLINE: AGTC-501 Shows Positive 24-Month Data in X-Linked Retinitis Pigmentosa| Image Credit: V2osk/Unsplash
October 19th 2024

SKYLINE: AGTC-501 Reports Positive 24-Month Data in X-Linked Retinitis Pigmentosa

Connor Iapoce
ARCHER: ANX007 Mitigates Visual Acuity Loss in Geographic Atrophy| Image Credit: ASRS
October 19th 2024

ARCHER: ANX007 Mitigates Visual Acuity Loss in Geographic Atrophy

Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.